These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32344802)

  • 1. The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.
    van der Merwe J; Steenekamp J; Steyn D; Hamman J
    Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32344802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
    Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
    Pouton CW
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.
    Zhang X; Xing H; Zhao Y; Ma Z
    Pharmaceutics; 2018 Jun; 10(3):. PubMed ID: 29937483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
    Zoeller T; Dressman JB; Klein S
    Int J Pharm; 2012 Jul; 430(1-2):176-83. PubMed ID: 22531855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
    Budiman A; Lailasari E; Nurani NV; Yunita EN; Anastasya G; Aulia RN; Lestari IN; Subra L; Aulifa DL
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emulsion forming drug delivery system for lipophilic drugs.
    Wadhwa J; Nair A; Kumria R
    Acta Pol Pharm; 2012; 69(2):179-91. PubMed ID: 22568032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole.
    Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ
    Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theory and practice of supersaturatable formulations for poorly soluble drugs.
    Kawakami K
    Ther Deliv; 2015 Mar; 6(3):339-52. PubMed ID: 25853309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.
    Bazzo GC; Pezzini BR; Stulzer HK
    Int J Pharm; 2020 Oct; 588():119741. PubMed ID: 32783978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin.
    Taupitz T; Dressman JB; Klein S
    Eur J Pharm Biopharm; 2013 May; 84(1):208-18. PubMed ID: 23246797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
    Chella N; Daravath B; Kumar D; Tadikonda RR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of solid dispersion for improving solubility, dissolution & bioavailability of herbal extracts, enriched fractions, and bioactives.
    Mohapatra D; Agrawal AK; Sahu AN
    J Microencapsul; 2021; 38(7-8):594-612. PubMed ID: 34338596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.
    Patel K; Shah S; Patel J
    Daru; 2022 Jun; 30(1):165-189. PubMed ID: 35437630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
    Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
    Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.